Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Spectros Corporation Stanford University University of California University of Pennsylvania |
---|---|
Information provided by: | Spectros Corporation |
ClinicalTrials.gov Identifier: | NCT00671385 |
The purposes of this study is to establish normal optical values of breast tissue in the general population. This will allow for establishing normals for breast composition, and is expected to be useful in the classification of breast lesions into groups such as cysts, benign growths, inflammatory lesions, and possibly early breast cancer.
Condition |
---|
Breast Lesions Breast Cyst Early-Stage Breast Cancer Benign Growth, Breast |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Early Screening of Breast Cancer Using Radiation-Free Pressure-Free Optical Scanning |
Estimated Enrollment: | 2000 |
Study Start Date: | April 2008 |
Estimated Study Completion Date: | April 2011 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
Women 21-50 years old
Women without a diagnosis of cancer or a history of cancer.
|
Ages Eligible for Study: | 21 Years to 50 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Women 18-50 with who EITHER (a) have a region of interest but without a diagnosis, or (b) are healthy volunteers without breast cancer.
Inclusion Criteria:
You must be female
Exclusion Criteria:
Contact: Lizzy van Thillo, AA | 650-851-4040 ext 549 | lizzy@spectros.com |
Contact: Carrie Bomarito, RN | 650-851-4040 ext 0 | info@spectros.com |
United States, California | |
Spectros Corporation | Recruiting |
Portola Valley, California, United States, 94029 | |
Contact: Lizzy van Thillo, AA 650-851-4040 ext 549 lizzy@spectros.com | |
Contact: Carrie Bomarito, RN 640-851-4040 ext 0 info@spectros.com |
Study Director: | David A Benaron, MD | Spectros Corporation |
Responsible Party: | Spectros Corporation ( Clinical Studies Manager ) |
Study ID Numbers: | SPE-BCA-003, CA126441, CA083597 |
Study First Received: | May 1, 2008 |
Last Updated: | May 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00671385 |
Health Authority: | United States: Institutional Review Board |
screening compositional analysis metabolism breast breast cyst |
breast infection breast inflammation lipoma benign growth Women without a diagnosis for a region of interest in the breast |
Breast Cyst Skin Diseases Lipoma Breast Neoplasms |
Cysts Mastitis Breast Diseases Inflammation |
Neoplasms Neoplasms by Site |